SCH-57,790

Overview

SCH-57,790 is a chemical compound that acts as a selective antagonist of the dopamine D1 receptor. It is primarily used in scientific research to study the role of D1 receptors in the brain and their involvement in various neurological and psychiatric conditions.

Chemical Structure and Properties

SCH-57,790 is a member of the benzazepine class of compounds. Its chemical structure is characterized by a benzazepine core, which is a bicyclic structure consisting of a benzene ring fused to an azepine ring. The specific molecular formula of SCH-57,790 is C18H19Cl2NO, and it has a molecular weight of 336.26 g/mol.

Mechanism of Action

SCH-57,790 functions as a selective antagonist at the dopamine D1 receptor. By binding to these receptors, it inhibits the action of dopamine, a neurotransmitter that plays a crucial role in the regulation of mood, motivation, and reward. The blockade of D1 receptors by SCH-57,790 allows researchers to investigate the specific contributions of these receptors to various physiological and behavioral processes.

Research Applications

SCH-57,790 is widely used in preclinical research to explore the role of dopamine D1 receptors in:

• Parkinson's disease: Understanding the involvement of D1 receptors in motor control and the pathophysiology of Parkinson's disease.
• Schizophrenia: Investigating the potential role of D1 receptor dysfunction in the cognitive and negative symptoms of schizophrenia.
• Addiction: Studying the contribution of D1 receptors to the reinforcing effects of drugs of abuse, such as cocaine and amphetamines.
• Cognitive function: Examining the impact of D1 receptor activity on learning, memory, and executive function.

Pharmacokinetics

The pharmacokinetic profile of SCH-57,790 includes its absorption, distribution, metabolism, and excretion. However, detailed pharmacokinetic data specific to SCH-57,790 is limited, as it is primarily used in laboratory settings rather than clinical applications.

Safety and Toxicology

As a research chemical, SCH-57,790 is not intended for human use, and its safety profile in humans is not well-established. In laboratory studies, it is important to handle SCH-57,790 with care, following appropriate safety protocols to avoid exposure.

Also see

• Dopamine receptor
• Dopamine D1 receptor
• Dopamine antagonist
• Neuropharmacology
• Benzazepine